Vendor, Tarrytown, NY
Regeneron Pharmaceuticals Inc.
UEI N3F9MH7E6HD6, CAGE 544P9
1 award and $2,684,549 obligated between July 30, 2026 and July 30, 2026, 100% under full and open competition, against 2.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $2,684,549 |
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541711 | $2,684,549 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100201700016CDefinitive Contract, July 30, 2026, Full and Open Competition, 2 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Inmazeb Ebola TherapeuticsNAICS 541711, PSC AN13 | $2,684,549 |
- Places of performance
- New York
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards